DBV Technologies Stock price

Equities

DBV

FR0010417345

Pharmaceuticals

Market Closed - Euronext Paris 12:35:16 2024-03-28 pm EDT 5-day change 1st Jan Change
1.331 EUR 0.00% Intraday chart for DBV Technologies -2.85% -28.02%
Sales 2024 * 6.53M 7.05M Sales 2025 * 4.89M 5.27M Capitalization 128M 138M
Net income 2024 * -107M -115M Net income 2025 * -74M -79.85M EV / Sales 2024 * -6.5 x
Net cash position 2024 * 170M 184M Net cash position 2025 * 224M 241M EV / Sales 2025 * -19.6 x
P/E ratio 2024 *
-1.73 x
P/E ratio 2025 *
-3.1 x
Employees 105
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.1%
More Fundamentals * Assessed data
Dynamic Chart
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading MT
DBV Technologies: down sharply, cash flow not reassuring CF
DBV Technologies S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : DBV Technologies S.A., 2023 Earnings Call, Mar 07, 2024
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading MT
Global markets live: BAE Systems, HSBC, Nvidia, Tesla, Boeing... Our Logo
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Tuesday Trading MT
More news
1 week-1.41%
Current month-0.97%
1 month-3.06%
3 months-31.39%
6 months-49.16%
Current year-28.02%
More quotes
1 week
1.31
Extreme 1.308
1.35
1 month
1.31
Extreme 1.305
1.55
Current year
1.10
Extreme 1.095
1.90
1 year
1.10
Extreme 1.095
4.30
3 years
1.10
Extreme 1.095
11.70
5 years
1.10
Extreme 1.095
25.44
10 years
1.10
Extreme 1.095
86.64
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 18-11-28
Director of Finance/CFO 54 Nov. 05
Chief Tech/Sci/R&D Officer 59 19-07-21
Members of the board TitleAgeSince
Director/Board Member 61 21-02-28
Chairman 73 18-06-21
Director/Board Member 65 15-03-05
More insiders
Date Price Change Volume
24-03-28 1.331 0.00% 32,979
24-03-27 1.331 0.00% 38,672
24-03-26 1.331 -0.22% 40,506
24-03-25 1.334 +0.60% 47,956
24-03-22 1.326 -1.78% 63,477

Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT

More quotes
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.331 EUR
Average target price
4.783 EUR
Spread / Average Target
+259.38%
Consensus
  1. Stock
  2. Equities
  3. Stock DBV Technologies - Euronext Paris